Bibliography

Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,000 peer-reviewed publications.

The CPRD bibliography is updated on a monthly basis (last updated 3 April 2019) and papers are listed below.

If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.

 

Export 2216 results:
Author Title Type [ Year(Asc)]
2019
A. M. Gallagher, Dedman, D., Padmanabhan, S., Leufkens, H. G. M., and de Vries, F., “The accuracy of date of death recording in the Clinical Practice Research Datalink GOLD database in England compared with the Office for National Statistics death registrations”, Pharmacoepidemiol Drug Saf, 2019.
C. Becker, Jick, S. S., and Meier, C. R., “ACE inhibitor use and risk of cataract: a case-control analysis”, Br J Ophthalmol, 2019.
M. Gharbi, Drysdale, J. H., Lishman, H., Goudie, R., Molokhia, M., Johnson, A. P., Holmes, A. H., and Aylin, P., “Antibiotic management of urinary tract infection in elderly patients in primary care and its association with bloodstream infections and all cause mortality: population based cohort study”, Bmj, vol. 364, p. l525, 2019.
J. Vavanikunnel, Charlier, S., Becker, C., Schneider, C., Jick, S. S., Meier, C. R., and Meier, C., “Association between glycemic control and risk of fracture in diabetic patients: A nested case-control study”, J Clin Endocrinol Metab, 2019.
F. Montastruc, Nie, R., Loo, S., Rej, S., Dell'Aniello, S., Micallef, J., Suissa, S., and Renoux, C., “Association of Aripiprazole With the Risk for Psychiatric Hospitalization, Self-harm, or Suicide”, JAMA Psychiatry, 2019.
H. Strongman, Brown, A., Smeeth, L., and Bhaskaran, K., “Body mass index and Hodgkin's lymphoma: UK population-based cohort study of 5.8 million individuals”, Br J Cancer, 2019.
A. V. Gayle, Axson, E. L., Bloom, C. I., Navaratnam, V., and Quint, J. K., “Changing causes of death for patients with chronic respiratory disease in England, 2005-2015”, Thorax, 2019.
S. V. Ramagopalan, Carroll, R., Ulvestad, M., Mehmud, F., and Alikhan, R., “The changing face of venous thromboembolism management in England”, Future Cardiol, 2019.
R. Persson and Jick, S., “Clinical implications of the association between fluoroquinolones and tendon rupture: the magnitude of the effect with and without corticosteroids”, Br J Clin Pharmacol, 2019.
L. Fiaschi, Nelson-Piercy, C., Deb, S., King, R., and Tata, L. J., “Clinical management of nausea and vomiting in pregnancy and hyperemesis gravidarum across primary and secondary care: a population based study”, Bjog, 2019.
F. Nissen, Douglas, I. J., Mullerova, H., Pearce, N., Bloom, C. I., Smeeth, L., and Quint, J. K., “Clinical profile of predefined asthma phenotypes in a large cohort of UK primary care patients (Clinical Practice Research Datalink)”, J Asthma Allergy, vol. 12, pp. 7-19, 2019.
A. Dregan, Matcham, F., Harber-Aschan, L., Rayner, L., Brailean, A., Davis, K., Hatch, S., Pariante, C., Armstrong, D., Stewart, R., and Hotopf, M., “Common mental disorders within chronic inflammatory disorders: a primary care database prospective investigation”, Ann Rheum Dis, 2019.
S. Suissa, Dell'Aniello, S., and Ernst, P., “Comparative effectiveness and safety of LABA-LAMA versus LABA-ICS treatment of COPD in real world clinical practice”, Chest, 2019.
J. L. Hong, Webster-Clark, M., M. Funk, J., Sturmer, T., Dempster, S. E., Cole, S. R., Herr, I., and LoCasale, R., “Comparison of Methods to Generalize Randomized Clinical Trial Results Without Individual-Level Data for the Target Population”, Am J Epidemiol, vol. 188, pp. 426-437, 2019.
A. Wolf, Dedman, D., Campbell, J., Booth, H., Lunn, D., Chapman, J., and Myles, P., “Data resource profile: Clinical Practice Research Datalink (CPRD) Aurum”, Int J Epidemiol, 2019.
C. S. Arhi, Markar, S., Burns, E. M., Bouras, G., Bottle, A., Hanna, G., Aylin, P., Ziprin, P., and Darzi, A., “Delays in referral from primary care are associated with a worse survival in patients with esophagogastric cancer”, Dis Esophagus, 2019.
D. Yu, Jordan, K. P., Snell, K. I. E., Riley, R. D., Bedson, J., Edwards, J. J., Mallen, C. D., Tan, V., Ukachukwu, V., Prieto-Alhambra, D., Walker, C., and Peat, G., “Development and validation of prediction models to estimate risk of primary total hip and knee replacements using data from the UK: two prospective open cohorts using the UK Clinical Practice Research Datalink”, Ann Rheum Dis, vol. 78, pp. 91-99, 2019.
S. V. Ramagopalan, Graham, S., Carroll, R., Raluy-Callado, M., Nordstrom, B. L., Donaldson, R., Colby, C., Mehmud, F., and Alikhan, R., “Discontinuation and primary care visits in nonvalvular atrial fibrillation patients treated with apixaban or warfarin”, J Comp Eff Res, 2019.
I. Karp, Sivaswamy, A., and Booth, C., “Does the use of incretin-based medications increase the risk of cancer in patients with type-2 diabetes mellitus?”, Pharmacoepidemiol Drug Saf, 2019.
Y. Tao and Fu, H., “Doubly robust estimation of the weighted average treatment effect for a target population”, Stat Med, vol. 38, pp. 315-325, 2019.
A. Jaggi, Nazir, J., Fatoye, F., Siddiqui, E., Choudhury, N., Argoubi, R., Ali, M., de Ridder, D., and Drake, M. J., “Drug utilization patterns and healthcare resource use and costs in patients with neurogenic bladder in the United Kingdom: A retrospective primary care database study”, Neurourol Urodyn, 2019.
O. M. Moussa, Ardissino, M., Kulatilake, P., Faraj, A., Muttoni, E., Darzi, A., Ziprin, P., Scholtz, S., and Purkayastha, S., “Effect of body mass index on depression in a UK cohort of 363 037 obese patients: A longitudinal analysis of transition”, Clin Obes, p. e12305, 2019.
M. J. Cook, Sorial, A. K., Lunt, M., Board, T. N., and O'Neill, T. W., “Effect of timing and duration of statin exposure on risk of hip or knee revision arthroplasty: a population-based cohort study”, J Rheumatol, 2019.
M. C. Gulliford, Prevost, A. T., Charlton, J., Juszczyk, D., Soames, J., McDermott, L., Sultana, K., Wright, M., Fox, R., Hay, A. D., Little, P., Moore, M. V., Yardley, L., and Ashworth, M., “Effectiveness and safety of electronically delivered prescribing feedback and decision support on antibiotic use for respiratory illness in primary care: REDUCE cluster randomised trial”, Bmj, vol. 364, p. l236, 2019.
M. C. Gulliford, Juszczyk, D., Prevost, A. T., Soames, J., McDermott, L., Sultana, K., Wright, M., Fox, R., Hay, A. D., Little, P., Moore, M., Yardley, L., Ashworth, M., and Charlton, J., “Electronically delivered interventions to reduce antibiotic prescribing for respiratory infections in primary care: cluster RCT using electronic health records and cohort study”, Health Technol Assess, vol. 23, pp. 1-70, 2019.
K. J. Roberts, Bannister, C. A., and Schrem, H., “Enzyme replacement improves survival among patients with pancreatic cancer: Results of a population based study”, Pancreatology, vol. 19, pp. 114-121, 2019.
L. Horne, Ashfaq, A., MacLachlan, S., Sinsakul, M., Qin, L., LoCasale, R., and Wetmore, J. B., “Epidemiology and health outcomes associated with hyperkalemia in a primary care setting in England”, BMC Nephrol, vol. 20, p. 85, 2019.
R. M. Joseph, van Staa, T. P., Lunt, M., Abrahamowicz, M., and Dixon, W. G., “Exposure measurement error when assessing current glucocorticoid use using UK primary care electronic prescription data”, Pharmacoepidemiol Drug Saf, vol. 28, pp. 179-186, 2019.
J. Jackson, Lewis, N. V., Feder, G. S., Whiting, P., Jones, T., Macleod, J., and Redaniel, M. T., “Exposure to domestic violence and abuse and consultations for emergency contraception: nested case-control study in a UK primary care dataset”, Br J Gen Pract, vol. 69, pp. e199-e207, 2019.
M. H. Secrest, Platt, R. W., Dormuth, C. R., Chateau, D., Targownik, L., Nie, R., Doyle, C. M., Dell'Aniello, S., and Filion, K. B., “Extreme restriction design as a method for reducing confounding by indication in pharmacoepidemiologic research”, Pharmacoepidemiol Drug Saf, 2019.
A. Bottle, Kim, D., Hayhoe, B., Majeed, A., Aylin, P., Clegg, A., and Cowie, M. R., “Frailty and comorbidity predict first hospitalisation after heart failure diagnosis in primary care: population-based observational study in England”, Age Ageing, 2019.
C. Rebordosa, Plana, E., Aguado, J., Thomas, S., Garcia-Gil, E., Perez-Gutthann, S., and Castellsague, J., “GOLD assessment of COPD severity in the Clinical Practice Research Datalink (CPRD)”, Pharmacoepidemiol Drug Saf, vol. 28, pp. 126-133, 2019.
C. D. Steer, Macleod, J., Tilling, K., Lim, A. G., Marsden, J., Millar, T., Strang, J., Telfer, M., Whitaker, H., Vickerman, P., and Hickman, M., “Health Services and Delivery Research”, in The impact of opiate substitution treatment on mortality risk in drug addicts: a natural experiment study, Southampton (UK): NIHR Journals Library Copyright (c) Queen's Printer and Controller of HMSO 2019. This work was produced by Steer et al. under the terms of a commissioning contract issued by the Secretary of State for Health and Social Care. This issue may be freely repro, 2019.
L. Harris, Graham, S., MacLachlan, S., Exuzides, A., and Jacob, S., “Healthcare resource utilization by patients with treatment-refractory myasthenia gravis in England”, J Med Econ, pp. 1-7, 2019.
M. Ardissino, Moussa, O., Tang, A., Muttoni, E., Ziprin, P., and Purkayastha, S., “Idiopathic intracranial hypertension in the British population with obesity”, Acta Neurochir (Wien), vol. 161, pp. 239-246, 2019.
J. L. Atkins, Delgado, J., Pilling, L. C., Bowman, K., Masoli, J. A. H., Kuchel, G. A., Ferrucci, L., and Melzer, D., “Impact of Low Cardiovascular Risk Profiles on Geriatric Outcomes: Evidence From 421,000 Participants in Two Cohorts”, J Gerontol A Biol Sci Med Sci, vol. 74, pp. 350-357, 2019.
J. T. H. Nielen, Dagnelie, P. C., Boonen, A., Klungel, O., van den Bemt, B., and de Vries, F., “Impact of the definition of osteoarthritis and of the timing of its onset on the association between type 2 diabetes mellitus and osteoarthritis: Clinical Practice Research Datalink”, Diabetes Res Clin Pract, vol. 148, pp. 240-248, 2019.
K. C. Chang, Vamos, E. P., Palladino, R., Majeed, A., Lee, J. T., and Millett, C., “Impact of the NHS Health Check on inequalities in cardiovascular disease risk: a difference-in-differences matching analysis”, J Epidemiol Community Health, vol. 73, pp. 11-18, 2019.
K. Davies, Johnson, E. L., Hollen, L., Jones, H. M., Lyttle, M. D., Maguire, S., and Kemp, A. M., “Incidence of medically attended paediatric burns across the UK”, Inj Prev, 2019.
T. S. Field, Weijs, B., Curcio, A., Giustozzi, M., Sudikas, S., Katholing, A., Wallenhorst, C., Weitz, J. I., Cohen, A. T., and Martinez, C., “Incident Atrial Fibrillation, Dementia and the Role of Anticoagulation: A Population-Based Cohort Study”, Thromb Haemost, 2019.
E. Badrick, Renehan, I., and Renehan, A. G., “Linkage of the UK Clinical Practice Research Datalink with the national cancer registry”, Eur J Epidemiol, vol. 34, pp. 101-102, 2019.
M. Sabido, Thilo, H., and Guido, G., “Long-term effectiveness of bisoprolol in patients with angina: A real-world evidence study”, Pharmacol Res, vol. 139, pp. 106-112, 2019.
J. A. Rassen, Bartels, D. B., Schneeweiss, S., Patrick, A. R., and Murk, W., “Measuring prevalence and incidence of chronic conditions in claims and electronic health record databases”, Clin Epidemiol, vol. 11, pp. 1-15, 2019.
R. E. Farmer, Ford, D., Mathur, R., Chaturvedi, N., Kaplan, R., Smeeth, L., and Bhaskaran, K., “Metformin use and risk of cancer in patients with type 2 diabetes: a cohort study of primary care records using inverse probability weighting of marginal structural models”, Int J Epidemiol, 2019.
R. Brauer, Herrero-Zazo, M., Barlow, D. J., Gaughran, F., Taylor, D., and Howard, L. M., “Minocycline and the risk of acute psychiatric events in adolescence: A self-controlled case series”, J Psychopharmacol, p. 269881118821852, 2019.
J. M. Ryan, Peterson, M. D., Ryan, N., Smith, K. J., N, E. O. 'Connell, Liverani, S., Anokye, N., Victor, C., and Allen, E., “Mortality due to cardiovascular disease, respiratory disease, and cancer in adults with cerebral palsy”, Dev Med Child Neurol, 2019.
R. Persson, Lee, S., Yood, M. U., Wagner, M., Minton, N., Niemcryk, S., Lindholm, A., Evans, A., and Jick, S., “Multi-database study of multiple sclerosis: identification, validation and description of MS patients in two countries”, J Neurol, 2019.
G. Glover, Williams, R., Tompkins, G., and Oyinlola, J., “An observational study of the use of acute hospital care by people with intellectual disabilities in England”, J Intellect Disabil Res, vol. 63, pp. 85-99, 2019.
R. Williams, Kothny, W., Serban, C., Lopez-Leon, S., and Schlienger, R., “Pancreatic safety of vildagliptin in patients with type 2 diabetes mellitus: A European, noninterventional, postauthorization safety study”, Endocrinology, Diabetes & Metabolism, vol. 2, no. 2, 2019.
S. F. Weng, Vaz, L., Qureshi, N., and Kai, J., “Prediction of premature all-cause mortality: A prospective general population cohort study comparing machine-learning and standard epidemiological approaches”, PLoS One, vol. 14, p. e0214365, 2019.
[Page last reviewed 12 April 2019]